Cardiovascular disease in survivors of hematopoietic cell transplantation. - Wikidata - wikimedia - TriplyDB

Cardiovascular disease in survivors of hematopoietic cell transplantation.

Cardiovascular disease in survivors of hematopoietic cell transplantation.

http://www.wikidata.org/entity/Q37624268

about

Arrhythmias in the setting of hematopoietic cell transplants.Prognostic Importance of Pretransplant Functional Capacity After Allogeneic Hematopoietic Cell Transplantation Cardiovascular Complications of Hematopoietic Stem Cell Transplantation.Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study.Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.Cardiovascular disease and physical activity in adult cancer survivors: a nested, retrospective study from the Atlantic PATH cohort.

P2860

Q36021536-F90DD138-4A40-4223-86A3-A3ABA50FF713 Q36478727-EC841F6A-0683-48DD-B7C0-9459B369BE63 Q36615092-D3587956-B4BF-478C-98C5-7CC07FD02A88 Q37159230-B1A842DD-BD5E-48A9-B27B-185762E10345 Q37213203-76EBDA92-BFC1-48B8-BFCC-0E70C75D1C5D Q38750270-48798D03-50BA-49AC-BE9E-6D8A9A799CB0 Q38797541-B8510C1B-EE93-4663-A29D-AFB8FE9E4C55 Q38798042-E52B4CB7-23C3-41FA-86FD-E4D8B769C318 Q44209882-E66CB831-1679-48A3-91D2-B57F163A16ED Q46015912-5F2F1E1A-596F-43F3-940F-6EE65B4497A3 Q46181268-D6DF2A24-AB41-4D0E-9C1D-F880B5B6AA67 Q54456824-2F87A252-832B-4AE9-8B66-36F107D47C32

P2860

Cardiovascular disease in survivors of hematopoietic cell transplantation.

http://www.wikidata.org/entity/Q37624268

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cardiovascular disease in survivors of hematopoietic cell transplantation.

@en

Cardiovascular disease in survivors of hematopoietic cell transplantation.

@nl

type

label

Cardiovascular disease in survivors of hematopoietic cell transplantation.

@en

Cardiovascular disease in survivors of hematopoietic cell transplantation.

@nl

prefLabel

Cardiovascular disease in survivors of hematopoietic cell transplantation.

@en

Cardiovascular disease in survivors of hematopoietic cell transplantation.

@nl

P1433

Q37624268-86DC90DE-FE47-4202-9346-47A9992F9465

P1476

Q37624268-D136B394-D504-4126-9C5D-88252EA8895B

P2093

Q37624268-85CC0E13-2CDF-459B-8369-3712DD7E10D6

P2860

Q37624268-0A90934B-431C-4F1F-91E4-DF29190FAD77

Q37624268-0BE274FE-EA78-47FC-A3B6-61CB0364AFAB

Q37624268-0CD82646-4FED-427F-A1D5-D20C85FA08A1

Q37624268-16F62BEC-3BA7-45FB-9E4C-1D3A834AC7A2

Q37624268-18102E03-B1A9-49BE-AF09-06D94BC93FF4

Q37624268-1A7DA011-7D73-40E5-84F2-EA1833E69DBF

Q37624268-1CAF8242-5FBF-44AF-B1E7-1FF1379368B7

Q37624268-1CCC2A99-D6FB-4567-B8F1-A40367518FEE

Q37624268-22941F23-1C50-4D5E-9953-48FBEE7672C4

Q37624268-26A8A1B7-8E5E-42D2-9122-3A3E673E1827

P304

Q37624268-E1F16E7E-AEFA-4074-83EF-4DBF404483CD

P31

Q37624268-74115FA5-5045-4A99-A35D-604A2E395EE1

P356

Q37624268-87AFE39C-B6A4-4140-86A8-2BE0E94B7848

P407

Q37624268-7ADC37FE-BD7A-4977-AA18-66C283F8EE48

P433

Q37624268-15589BBE-0E58-4D1B-82D1-C49ED500E83E

P478

Q37624268-17E4C4E1-78B8-439F-AE23-F3DC28A1BC36

P50

Q37624268-8B6B8CCD-279D-4CD8-96C3-259CD94A0C2B

P577

Q37624268-8AFB55FE-D177-4A73-9F7E-6432C6010DD8

P698

Q37624268-6163522C-CF15-4A37-ADF7-0771A470812B

P921

Q37624268-4D0D1041-F095-45F7-8709-6ED7A0285B4E

P932

Q37624268-716A3563-4DFE-46FA-B99D-8F8D5441B394

P356

P1433

P1476

Cardiovascular disease in survivors of hematopoietic cell transplantation

@en

P2093

Saro H Armenian

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial

Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens

Inflammation, atherosclerosis, and coronary artery disease

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review.

Inflammation, atherosclerosis, and stroke.

Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.

Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.

Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.

Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

P304

469-479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.28444

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24166350

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

3946330

http://www.w3.org/2001/XMLSchema#string